FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2288-2290 November 24, 2005 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Groszmann, R. J. PubMed Citation

Variceal bleeding is the most feared complication of portal hypertension in patients with cirrhosis and is a major cause of death. Treatments frequently include endoscopic banding or sclerotherapy of esophageal varices in parallel with splanchnic vasoconstrictors and intensive medical care.¹ Alternative interventions, such as decompressive surgical shunts, transjugular intrahepatic systemic shunts, and liver transplantation, are needed in patients with esophageal variceal bleeding refractory to endoscopic intervention or patients with bleeding from gastric or ectopic varices. However, the choice of therapy is based on the presence or absence of decompensated liver disease and is often influenced by local expertise. For example, . . . [Full Text of this Article]

Source Information

From the University of Nebraska Medical Center, Omaha.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.